Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
GRI BIO, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
04/25/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/25/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/25/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/25/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/25/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/24/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
03/09/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/18/2021 3 Kelly Leanne M. (CFO) has filed a Form 3 on Vallon Pharmaceuticals, Inc.
02/10/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/10/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/09/2021 3 Thorell Marella (Director) has filed a Form 3 on Vallon Pharmaceuticals, Inc.
02/09/2021 3 Baker David Charles (CEO) has filed a Form 3 on Vallon Pharmaceuticals, Inc.
02/09/2021 3 Levi Ofir (Director) has filed a Form 3 on Vallon Pharmaceuticals, Inc.
02/09/2021 3 Ammer Richard (10% Owner) has filed a Form 3 on Vallon Pharmaceuticals, Inc.
02/09/2021 3 SALMON Pharma GmbH (10% Owner) has filed a Form 3 on Vallon Pharmaceuticals, Inc.
02/09/2021 3 Toren Penny (SVP, Regul Affairs & Prog Mgmt) has filed a Form 3 on Vallon Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy